Communicating personalised statin therapy-effects as 10-year CVD-risk or CVD-free life-expectancy: does it improve decisional conflict? Three-armed, blinded, randomised controlled trial

OBJECTIVE: To determine whether communicating personalised statin therapy-effects obtained by prognostic algorithm leads to lower decisional conflict associated with statin use in patients with stable cardiovascular disease (CVD) compared with standard (non-personalised) therapy-effects. DESIGN: Hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaspers, Nicole E M, Visseren, Frank L J, van der Graaf, Yolanda, Smulders, Yvo M, Damman, Olga C, Brouwers, Corline, Rutten, Guy E H M, Dorresteijn, Jannick A N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287608/
https://www.ncbi.nlm.nih.gov/pubmed/34272216
http://dx.doi.org/10.1136/bmjopen-2020-041673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287608/
https://www.ncbi.nlm.nih.gov/pubmed/34272216
http://dx.doi.org/10.1136/bmjopen-2020-041673

Ejemplares similares